CURRENT DIABETES REVIEWS is a leading academic journal published by Bentham Science Publishers Ltd, dedicated to disseminating high-quality reviews and cutting-edge insights in the field of Endocrinology, Diabetes and Metabolism. Established in 1996 and actively publishing from 2005 to 2024, this journal holds a prestigious position within the academic community, evidenced by its Q2 ranking in both relevant categories for 2023 and its impactful presence in Scopus, where it ranks #83 out of 244 in Endocrinology and Diabetes and Metabolism. Despite being a subscription-based journal, it provides researchers, healthcare professionals, and students with valuable contributions that significantly advance the understanding of diabetes and related metabolic disorders. With a commitment to promoting interdisciplinary collaboration and innovation, CURRENT DIABETES REVIEWS serves as an essential resource for those seeking to stay abreast of the latest developments in diabetes research and therapies.

Bone Reports is a premier, peer-reviewed journal published by Elsevier that has been committed to advancing the field of orthopedics, sports medicine, and endocrinology since its inception as an open-access journal in 2015. With an ISSN of 2352-1872, this esteemed publication seeks to disseminate high-quality research that spans a diverse array of topics related to bone health, metabolic diseases, and musculoskeletal disorders. The journal boasts an impressive impact factor, contributing significantly to its recognition, with a Q2 ranking in Orthopedics and Sports Medicine and a Q3 ranking in Endocrinology, Diabetes, and Metabolism as of 2023. This open-access model enhances accessibility and engagement, allowing researchers, professionals, and students alike to stay at the forefront of developments in these critical areas. With an emphasis on rigorous methodology and innovative findings, Bone Reports is poised to become a vital resource for anyone interested in the latest advances in bone research and clinical applications.

CALCIFIED TISSUE INTERNATIONAL is a leading peer-reviewed journal published by Springer, dedicated to advancing our understanding of calcified tissues in relation to their physiological roles, pathophysiology, and therapeutic applications. With an impressive impact factor reflective of its importance in the field, this journal performs a crucial role in disseminating high-quality research that spans multiple disciplines, including Endocrinology, Orthopedics, and Sports Medicine. The journal is highly regarded within its respective categories, achieving Q1 rankings in Orthopedics and Sports Medicine, and demonstrating its commitment to excellence in scientific inquiry. While the journal operates under a traditional subscription model, it remains accessible to researchers and practitioners who seek to stay informed on the latest advancements and innovations in the study of calcified tissues. Established in 1973, CALCIFIED TISSUE INTERNATIONAL continues to be a vital resource for researchers, healthcare professionals, and students keen on exploring the intricate relationships between calcification processes and human health.

OSTEOPOROSIS INTERNATIONAL, published by SPRINGER LONDON LTD, stands at the forefront of research in the field of bone health and metabolic disorders, specifically focusing on osteoporosis and related conditions. With an ISSN of 0937-941X and impressive ranking in the Q1 category of both Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) for 2023, this journal ranks 47th out of 244 in its category, placing it solidly within the top 20% of its field, according to Scopus metrics. The journal, active since 1990, aims to foster a deep understanding of osteoporosis through high-quality research articles, reviews, and clinical insights that are pivotal for healthcare professionals, researchers, and students alike. Although it does not offer open access, users can expect rigorous peer-reviewed content that significantly contributes to the advancement of knowledge in osteoporosis prevention, diagnosis, and treatment. With a dedicated readership and a commitment to excellence, OSTEOPOROSIS INTERNATIONAL plays a vital role in shaping the future of bone health research.

Diabetes Epidemiology and Management, published by Elsevier, is an innovative open-access journal that has been addressing the critical issues surrounding diabetes since its inception in 2021. This journal integrates a comprehensive exploration of the epidemiology, prevention, and management of diabetes, making it a pivotal resource within the fields of Endocrinology, Diabetes and Metabolism, and Internal Medicine. With a digital presence represented by E-ISSN 2666-9706, it currently holds a commendable position in the academic landscape, categorized in the Q3 quartile for both Endocrinology and Internal Medicine as per the 2023 metrics. The journal aims to enhance understanding and promote research on diabetes, offering authors a platform to share their findings with a global audience. Researchers, professionals, and students alike can benefit from this essential resource, which is dedicated to advancing the knowledge base and improving clinical practices in diabetes management. With open access options since 2021, the journal ensures that vital research is widely accessible, driving innovation and collaboration in the fight against diabetes.

The Journal of Bone and Mineral Research, published by Wiley, is a leading international journal dedicated to advancing the understanding of skeletal biology and bone health since its inception in 1986. With a strong focus on the intersection of endocrinology, diabetes, metabolism, and orthopedics and sports medicine, this journal holds a prestigious Q1 ranking in both fields for 2023, highlighting its significant impact and relevance in the scientific community. The journal attracts high-quality research, as evidenced by its Scopus ranking—7th in Orthopedics and Sports Medicine and 25th in Endocrinology. This makes it a vital resource for researchers, clinicians, and students keen on exploring the intricacies of bone metabolism and disorders. While the journal operates on a subscription basis, it remains committed to disseminating pivotal research and fostering innovations that enhance bone health worldwide.

Archives of Endocrinology Metabolism is a distinguished open-access journal dedicated to advancing the field of endocrinology and metabolism. Published by SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA, this journal has established itself as a vital platform for researchers, clinicians, and scholars since its inception in 2008. With an ISSN of 2359-3997 and E-ISSN of 2359-4292, it aims to disseminate high-quality research articles that explore the latest advancements in endocrinology, diabetes, and metabolism. As of 2023, it has achieved a commendable Q3 ranking in its field, demonstrating its relevancy and increasing visibility among peers. The journal's focus spans various sub-disciplines, including hormonal regulation, metabolic disorders, and innovative therapies, making it an essential resource for both emerging professionals and seasoned experts alike. With a rich repository of research from Brazil and beyond, Archives of Endocrinology Metabolism continuously seeks to contribute to the ongoing dialogue and collaboration within the global scientific community.

Actualizaciones en Osteología is a peer-reviewed academic journal dedicated to the dissemination of pivotal research in the field of osteoporosis and mineral metabolism. Published by ASOCIACIÓN ARGENTINA DE OSTEOLOGÍA & METABOLISMO MINERAL, this journal serves as a vital resource for professionals, researchers, and students in medicine, particularly within the subdomains of endocrinology, orthopedics, and radiology. With its ISSN 1669-8975 and E-ISSN 1669-8983, the journal has been operational since 2009 and is located in Córdoba, Argentina. Its increasing relevance is underscored by its categorization in the Q4 quartile across multiple medical disciplines, indicating a committed effort to enhance knowledge in these areas. Although it operates without an open-access model, the journal provides critical insights and updates that are making a significant impact in the evolving landscape of osteology and related fields. By participating in the discussions presented, contributors and readers alike can stay abreast of the latest innovations and research findings in bone health.

Journal of Hard Tissue Biology, published by JOURNAL HARD TISSUE BIOLOGY, is a pivotal resource for researchers and practitioners engaged in the multifaceted fields of biochemistry, biomaterials, cell biology, dentistry, and orthopedics. With an ISSN of 1341-7649 and a publication history spanning from 2003 to 2024, this journal aims to disseminate innovative findings and review articles that contribute to the understanding of hard tissue structures and their applications in medicine. Despite its current Q4 ranking across several categories, including Biochemistry and Oral Medicine, the journal serves as a critical platform for emerging research, appealing to those dedicated to advancing the science of hard tissues. While it operates under a subscription model, the articles published here are essential for anyone seeking comprehensive insights into the biological, mechanical, and clinical aspects of hard tissues. The journal's commitment to excellence and its ongoing contributions make it an indispensable tool for students, researchers, and professionals aiming to enhance their understanding of hard tissue biology.

JOURNAL OF BONE AND MINERAL METABOLISM, published by SPRINGER JAPAN KK, is a leading peer-reviewed journal dedicated to advancing the field of bone and mineral research since its establishment in 1988. With ISSN 0914-8779 and E-ISSN 1435-5604, this esteemed journal offers a platform for high-quality research that intersects Endocrinology, Diabetes and Metabolism, Orthopedics and Sports Medicine, and related disciplines. Recognized for its rigorous standards, it holds a commendable Q2 ranking in multiple categories, reflecting its broad influence and relevance in contemporary medical research. Researchers and practitioners alike benefit from its evidence-based articles and insights, which contribute significantly to our understanding of metabolic bone diseases and mineral homeostasis. Although not an open-access journal, it still provides essential information and advancements crucial for professionals and scholars dedicated to improving clinical outcomes and enhancing patient care in these vital areas. To learn more, please explore the journal's archives and latest publications.